Clinicopathologic features of single bone metastasis in breast cancer
نویسندگان
چکیده
منابع مشابه
Clinicopathologic features and clinical outcomes of gastric cancer patients with bone metastasis.
OBJECTIVE We conducted a retrospective analysis to evaluate the clinical manifestations and outcomes of a population of gastric cancer patients with bone metastasis. METHODS The subjects were 31 gastric cancer patients who were diagnosed with bone metastasis between January 2000 and December 2010. RESULTS The overall median survival time (MST) was 100 days. The results of a multivariate ana...
متن کاملBone metastasis risk factors in breast cancer
Bone is the single most frequent site for bone metastasis in breast cancer patients. Patients with bone-only metastasis have a fairly good prognosis when compared with patients with visceral disease. Nevertheless, cancer-induced bone disease carries an important risk of developing skeletal related events that impact quality of life (QoL). It is therefore particularly important to stratify patie...
متن کاملCancer metastasis at a glance: A brief view of Breast Cancer Brain Metastasis
Cancer initiation and progression is a challenging scenario through developmental processes, which may be more complicated by occurrence of metastasis. Basically, diverse genetic alterations, including mutations, formation of truncated proteins and related pathways play key roles either in diagnosis or the most influential therapeutic purposes. ...
متن کاملOsthole inhibits bone metastasis of breast cancer
Bone is one of the most common sites for breast cancer metastasis, which greatly contributes to patient morbidity and mortality. Osthole, a major extract from Cnidium monnieri (L.), exhibits many biological and pharmacological activities, however, its potential as a therapeutic agent in the treatment of breast cancer bone metastases remain poorly understood. In this study, we set out to investi...
متن کاملCOX2 regulation of breast cancer bone metastasis
High expression levels of cyclooxygenase 2 expression and infiltration by regulatory T cells (Tregs) are often associated with tumor progression. We have recently reported a prostaglandin E2 (PGE2)-dependent recruitment of Tregs to the tumor, suggesting that targeting specific PGE2 receptors may constitute a valuable approach to ablate the immuno-editing that occurs along with disease progression.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Medicine
سال: 2021
ISSN: 0025-7974,1536-5964
DOI: 10.1097/md.0000000000024164